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Abstract 
 
Objectives  
Firstly, to identify subthalamic region stimulation clusters that predict 
maximum improvement in rigidity, bradykinesia and tremor, or emergence of 
side-effects; and secondly, to map-out the cortical fingerprint, mediated by the 
hyperdirect pathways which predict maximum efficacy. 
 
Methods 
High angular resolution diffusion imaging in twenty patients with advanced 
Parkinson’s disease was acquired prior to bilateral subthalamic nucleus deep 
brain stimulation. All contacts were screened one-year from surgery for 
efficacy and side-effects at different amplitudes. Voxel-based statistical 
analysis of volumes of tissue activated models was used to identify significant 
treatment clusters. Probabilistic tractography was employed to identify cortical 
connectivity patterns associated with treatment efficacy. 
 
Results  
All patients responded well to treatment (46% mean improvement off 
medication UPDRS-III [p<0.0001]) without significant adverse events. Cluster 
corresponding to maximum improvement in tremor was in the posterior, 
superior and lateral portion of the nucleus. Clusters corresponding to 
improvement in bradykinesia and rigidity were nearer the superior border in a 
further medial and posterior location. The rigidity cluster extended beyond the 
superior border to the area of the zona incerta and Forel-H2 field. When the 
clusters where averaged, the coordinates of the area with maximum overall 
efficacy was X=-10(-9.5), Y=-13(-1) and Z=-7(-3) in MNI(AC-PC) space. 
Cortical connectivity to primary motor area was predictive of higher 
improvement in tremor; whilst that to supplementary motor area was predictive 
of improvement in bradykinesia and rigidity; and connectivity to prefrontal 
cortex was predictive of improvement in rigidity. 
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Interpretation 
These findings support the presence of overlapping stimulation sites within the 
subthalamic nucleus and its superior border, with different cortical connectivity 
patterns, associated with maximum improvement in tremor, rigidity and 
bradykinesia. 
 
1 Introduction 
 
Subthalamic nucleus (STN) high frequency stimulation is an established treatment in 
selected patients with advanced Parkinson’s disease (PD) (Krack et al., 2003; 
Limousin et al., 1995; A. Williams et al., 2010). The STN is thought to comprise 
functional subdivisions implicated in motor, associative and limbic functions with 
degrees of overlap (Garcia-Garcia et al., 2016; Haynes and Haber, 2013; Lambert et 
al., 2012; Nakano et al., 1990; Nambu et al., 1996; 1997). The motor subdivision 
occupies the so-called ‘dorsolateral’ aspect; nevertheless, the most effective target 
location has been contended. Authors have argued that contacts within the 
‘dorsolateral-STN’ give the biggest improvement in UPDRS-III(Johnsen et al., 2010; 
Weise et al., 2013; Wodarg et al., 2012); others have maintained that contacts ‘dorsal’ 
to the STN, in the zona incerta (ZI) area and Forel-H2 field, have superior efficacy 
(Cintas et al., 2003; Godinho et al., 2006; Maks et al., 2009; Plaha, 2006; Vergani et 
al., 2007; Voges et al., 2002; Yelnik et al., 2003; Zheng et al., 2009). A third group 
found both locations, or border contacts to be equally effective (Garcia-Garcia et al., 
2016; Hamel et al., 2003; Herzog et al., 2004; Lanotte et al., 2002; Yokoyama et al., 
2001; Zonenshayn et al., 2004). 
This discrepancy is attributed to several factors. One is reliance on surrogate markers 
such as microelectrode recording (Cintas et al., 2003; Godinho et al., 2006; Hamel et 
al., 2003; Lanotte et al., 2002; Maks et al., 2009; Vergani et al., 2007; Weise et al., 
2013; Yokoyama et al., 2001; Zonenshayn et al., 2004) and non-specific atlas 
coordinates or deformable atlases (Garcia-Garcia et al., 2016; Godinho et al., 2006; 
Hamel et al., 2003; Lanotte et al., 2002; Maks et al., 2009; Vergani et al., 2007; 
Yelnik et al., 2003; Zonenshayn et al., 2004) to identify the STN borders, not readily 
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discernible on low or intermediate field MRI (Cho et al., 2010). Another is using 
postoperative CT instead of stereotactic-MRI to confirm contact location within the 
target, overlooking errors introduced by brain shift or image co-registration 
(O’Gorman et al., 2009; Petersen et al., 2010). Complicating matters further, is the 
STN’s peculiar contour, double-oblique orientation and position within a junctional 
area where anatomical terms of location change, rendering localization description 
within the STN ambiguous (Hamani, 2004; Schaltenbrand et al., 1977; Yelnik et al., 
2007). The term “dorsal”, used when referring to the STN, is synonymous with 
“posterior” in the pons and “superior” in the thalamus (Coenen et al., 2008). Here we 
use unambiguous anatomical terms (superior/ inferior) to describe location within the 
STN. 
Lastly, overlooking the volume of tissue activated (VTA) and only examining centre 
of active contacts location ignores the effect contacts adjacent to the nucleus might 
have on nuclear cell bodies dendrites as well as axons within the white matter outside 
the nucleus (Gradinaru et al., 2009; Hardman et al., 2002; Lumsden et al., 2015; 
Schmidt and van Rienen, 2012; Sotiropoulos and Steinmetz, 2007; Zhang and Grill, 
2010) and limiting the comparison to the most effective contacts that landed in the 
chosen, predetermined target. 
A proposed mechanism of action of STN-DBS is through interrupting synchronised 
oscillations between STN and cortex (Bergman et al., 1998; Brown, 2003; Eusebio et 
al., 2009; Hammond et al., 2007; Hirschmann et al., 2011; Lalo et al., 2008; Litvak et 
al., 2011; Shimamoto et al., 2013) possibly through modulation of hyperdirect 
pathways (Alexander and Crutcher, 1990; Alexander et al., 1990; Brown et al., 2001; 
DeLong, 1990; Kitai and Kita, 1987; Nambu et al., 1997; 1996; 2002; J. A. Obeso et 
al., 2008; Parent and Hazrati, 1995; D. Williams et al., 2002). The objectives of this 
study were to identify the optimal STN stimulation site separately for improvement in 
rigidity, bradykinesia and tremor; identify stimulation sites accountable for common 
side-effects encountered with STN-DBS one-year after surgery; and explore the 
cortical connectivity or fingerprint of stimulation volumes, through these hyperdirect 
pathways, in a bottom-up fashion, by proceeding stepwise through the following 
aims:  
 
1. To create a group specific STN template by manually delineating, co-registering 
and averaging individual subthalamic nuclei 
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2. To screen all DBS contacts at amplitudes of 1,2,3 and 4 Volts for contralateral 
improvement in rigidity, bradykinesia and tremor; and emergence of side-effects 
3. To generate VTA models for all DBS contacts at these amplitudes 
4. To carry out a voxel based morphometry (VBM) style regression analysis of 
modelled VTAs and their associated efficacy and side-effect profiles 
5. To use probabilistic tractography from modelled VTAs of all DBS contacts to 
predefined cortical areas excluding tracts passing through the thalamus and 
striatum and only including tracts passing through the internal capsule 
(hyperdirect pathway) 
6. To generate a DBS-cortical connectivity matrix, using the output from the 
previous step, to test the predictive significance of cortical connectivity 
 
2 Materials and methods 
 
Ethical approval was granted by West London NHS REC (10/H0706/68).  All 
participants provided written informed consent.  
 
2.1 Patients 
 
Twenty patients (4 female), who met UK Brain Bank criteria for idiopathic 
Parkinson’s disease (Hughes et al., 1992), were included (Table1). Patients on the 
surgical waiting list for bilateral STN-DBS were recruited after selection by a 
multidisciplinary team of specialized movement disorders neurologists and functional 
neurosurgeons. All patients underwent formal neuropsychological assessment and 
structural brain MRI to rule out dementia and significant brain atrophy, respectively. 
Patients underwent L-DOPA challenge test during the routine selection process. 
Those with an improvement <25% on the UPDRS-III were excluded.  Inclusion in the 
present study was limited to patients who could tolerate and had no contraindications 
to a prolonged 3T-MRI scan.   
 
2.2 Preoperative diffusion MRI acquisition 
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This was performed on a 3T Siemens Magnetom Trio TIM Syngo MR-B17 using a 
padded 32-channel receive head coil to reduce discomfort and head motion. 
Siemens’ 511E-Advanced Echo Planar Imaging Diffusion WIP was used. In-plane 
acceleration was used (GRAPPA factor of 2) with partial Fourier 6/8. In plane 
resolution was 1.5×1.5mm
2 
(Field of view 219×219mm
2
, TR=12200ms, TE=99.6ms) 
and 85 slices were acquired with a 1.5mm thickness.  Diffusion-weighting with 
b=1500s/mm
2 
was applied along 128-directions uniformly distributed on the sphere 
and seven b=0s volumes were also acquired.  To correct for distortions all 
acquisitions were repeated with a reversed phase encoding direction (left to right and 
right to left phase encode) giving a total of 270 volumes acquired ([128+7]×2). Total 
acquisition time was 62 minutes. 
 
2.3 Surgical procedure and intraoperative-MRI 
 
Bilateral DBS (3389 Medtronic lead) implantation was performed under GA using a 
stereotactic MRI-guided and MRI-verified approach without microelectrode recording 
(Leksell frame G, Elekta) as detailed in previous publications  (Foltynie et al., 2011; 
Holl et al., 2010). Two stereotactic, pre-implantation scans were acquired, as part of 
the surgical procedure, to guide lead implantation; a T2-weighted axial scan (partial 
brain coverage around the STN) with voxel size of 1.0×1.0mm
2
 (slice 
thickness=2mm) and a T1-weighted 3D-MPRAGE scan with a (1.5mm)
3 
voxel size 
on a 1.5T Siemens Espree interventional MRI scanner. Three-dimensional distortion 
correction was carried out using the scanner’s built-in module. Target for the deepest 
contact was selected at the level of maximal rubral diameter (~5mm below the AC-PC 
line). To maximising DBS trace within the STN, the target was often chosen 1.5-2mm 
posterolateral to that described by Bejjani (Bejjani et al., 2000). Stereotactic imaging 
was repeated following lead implantation to confirm placement. A dual channel 
implantable pulse generator (IPG) (Activa PC, Medtronic, Minneapolis, Minn., USA) 
was then implanted in the infra-clavicular region on the same day of lead implantation 
or within a week, as a staged procedure. 
 
2.4 Outcome measures 
 
2.4.1 DBS contact efficacy and side-effect profile screening 
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DBS efficacy and side-effects screening was performed one-year from surgery. 
Medications were withdrawn for twelve-hours before assessment. DBS was switched 
off and after a five to ten-minute washout period, hemi-body (upper limb) rigidity, 
bradykinesia and tremor scores were assessed and rated from 0-4 (0=normal, 1=slight, 
2=mild, 3=moderate and 4=severe). Once baseline scores were documented, all 
contacts were screened one at a time using monopolar stimulation in four stimulation 
sessions with amplitudes of 1, 2, 3 and 4 volts, frequency of 130Hz and pulse width of 
60µs until the effect was established. A washout period was allowed between 
stimulation sessions until baseline was reached. Scores were reassessed for every 
session whilst evaluating the emergence and progression of stimulation-related side-
effects (i.e. facial pulling, dysarthria, diplopia and paraesthesia). An example 
screening sheet is provided in supplementary material.  
 
2.4.2 DBS-VTA modelling 
SureTune
® 
(Medtronic Inc. Minnesota), a DBS therapy planning platform was used to 
model VTAs around individual contacts and to manually delineate STN volume 
meshes.  The VTAs were created based on homogeneous finite element simulations of 
the distribution of the electric potential together with coupled axon cable models. 
Axon models were composed of 21 nodes, with a diameter of 2.5 µm and oriented in 
the vicinity of the lead in a perpendicular orientation. Specific VTA thresholds were 
calculated for every electrical setting taking in consideration the specific stimulation 
configuration, amplitude and pulse width as described by Åström and colleagues in 
order to generate DBS therapy VTA (Åström et al., 2015). Patient-specific tissue 
conductivity and patient-specific axon orientations were not considered. 
Intraoperative (pre- and post-implantation) stereotactic scans were co-registered. 
Scans were first manually aligned to pre-implantation MPRAGE scan before running 
automated co-registration with a restricted volume of fusion centred around the 
diencephalon/ mesencephalon. This was carried out to minimise registration error 
resulting from eventual brain shift incurred during surgery, despite minimal brain shift 
with our surgical technique (Petersen et al., 2010). Registration accuracy was 
carefully inspected and the process iterated if necessary. 
Pre-implantation T2-weighted stereotactic scans were used to generate STN meshes. 
Two experienced practitioners (HA a functional neurosurgeon and PM a movement 
disorders neurologist) carried out the process independently with <15% interrater 
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variability in identifying the boundaries of the STN across patients. The post-
implantation MPRAGE was used to fit the DBS lead model within the MRI artefact 
produced by the leads. Individual VTAs were then generated around each DBS 
contact with voltages of 1, 2, 3 and 4 volts resulting in 32 VTAs per patient. 
 
 
2.5 Image Pre-processing 
 
Pre-implantation MPRAGE scans were brain extracted using BET (Brain Extraction 
Tool, FSL v5.0) (Smith, 2002). A two-step procedure was used to register native 
scans to the MNI152 standard-space T1-weighted average structural template image 
(1mm resolution) (Grabner et al., 2006). The first step employed a linear (affine) 
transformation using FLIRT (FMRIB's Linear Image Registration Tool) using 12 
degrees of freedom (Jenkinson et al., 2002; Jenkinson and Smith, 2001). The output 
from this step was used to execute non-linear registration (second step) using FNIRT 
(FMRIB's Non-Linear Image Registration Tool) (Andersson et al., 2007). This 
process produced individual native-to-standard (MNI space) non-linear warp fields 
which were then applied to the STN and VTA volumetric meshes acquired from 
SureTune to transform all volumes to standard space.  
 
2.5.1 Diffusion pre-processing 
All diffusion weighted imaging (DWI) scans (with accompanying b=0 scans) were 
converted to NIfTI volumes and the diffusion gradient direction values and vectors 
were extracted using Volconv (MJ White, NHNN Neuroradiology Department, 
London UK). 
Opposite phase-encode blips acquisition pairs were used to estimate the susceptibility-
induced off-resonance field (Andersson et al., 2003) as implemented in FSL (Smith et 
al., 2004) and the two images were combined into a single corrected one using Topup 
(FSL v5.0), a tool for estimating and correcting susceptibility induced distortions 
prevalent in SSEPI DWI. Eddy (FSL v5.0) was then used to correct for eddy current 
distortions and subject movement (Andersson and Sotiropoulos, 2016). 
Patient averaged distortion corrected b=0 volume was registered to brain extracted 
structural image in native patient space (pre-implantation MPRAGE) with Flirt (FSL 
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v5.0) using linear registration with six degrees of freedom. The resultant 
transformation matrices were applied with the warp fields previously generated using 
non-linear registration between the structural in native patient space and the standard 
MNI152-1mm space producing diffusion-to-standard space warp fields and their 
corresponding inversions. 
BedpostX (FSL v5.0) was then used to estimate fibre orientations. Up to three 
crossing fibres were estimated in each brain voxel using model 2 and graphics 
processing unit (GPU) parallelization (Hernandez et al., 2013; Jbabdi et al., 2012). 
Probtrackx was used on these estimates to obtain global connectivity (i.e. the 
probability of the existence of a path through the diffusion field between any two 
distant points, a surrogate measure of anatomical connectivity) (Behrens et al., 2007). 
Using the obtained transformations to and from standard space, tractography 
protocols and masks were defined in MNI space. 
 
2.6 Analysis 
 
2.6.1 Model of VTAs and efficacy scores 
Group-average, bilateral STN templates and total VTA areas were generated from 
standardised (MNI space) individual STN volumes and DBS contacts VTAs using 
Fslmaths (FSL5.0) (see figures1 and 2). 
Right sided individual contact VTAs were lateralised to the left by swapping the x 
axis (x, y, z > -x, y, z) using Fslswapdim (FSL5.0). All VTAs were then merged using 
Fslmerge (FSL5.0) into a 4D data file. In each voxel, each of the VTAs (one for each 
of the 32 different stimulation conditions) was modelled as a linear combination of 
efficacy scores, and side-effects (0=absent, 1=transient or 2=persistent) within 
subject. A general linear model (GLM) was created with efficacy and side-effects 
variables to test against each voxel in corresponding VTAs in a single-group average 
design (each variable was tested individually). This analysis was carried out for each 
subject independently. The variables were demeaned and single group t-test with 
threshold-free cluster enhancement (TFCE) was used as test statistic (Smith and 
Nichols, 2009). Nonparametric permutation inference approach, similar to that 
commonly used for VBM and fMRI timeseries analysis, was carried out for each 
voxel using Randomise (FSL5.0) with 5000 permutations to build up the null 
distribution to test against as previously described (Winkler et al., 2014). Raw t-stat (t 
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statistic) images were then masked by the significant voxels from thresholded 
(α=0.05) t-stat images, also corrected for multiple comparisons. The resultant images 
from each subject were combined to form a group average. Cluster-based inference 
using Cluster (FSL5.0) was carried out to extract the clusters and local maxima in 
outputs. 
 
2.6.2 Tractography 
Probabilistic tractography was generated in ProbtrackX2 GPU version (Behrens 2007) 
(Hernandez-Fernandez et al., 2016) (FSL5.0) (number of samples=5000, curvature 
threshold=0.2, step length=0.5mm subsidiary fibre volume fraction threshold=0.01) 
(Jbabdi and Johansen-Berg, 2011). 
The combined (total) VTA areas were used to generate tractography (in MNI space) 
for the left and right hemispheres; additionally, tracts were generated from combined 
efficacy clusters instigating improvement in bradykinesia, tremor and rigidity as 
generated from the voxel-based morphometry (VBM) style DBS-contact VTA 
analysis in Randomise (FSL5.0). 
Waypoints were used in the internal capsule to isolate the streamlines to three cortical 
target areas; (1) primary motor cortex (M1 [Brodmann’s area 4]), (2) supplementary 
motor area (SMA) [Brodmann’s area 6] and (3) prefrontal cortex (PFC). CSF 
termination and mid-sagittal exclusion masks were applied to exclude false positive 
streamlines and commissural tracts respectively. To improve connectional contrast 
between the three targets, each of them was used as a target, while the other two were 
used as exclusion masks. For instance, to track the STN-M1 pathway, M1 was used as 
target, while SMA and PFC were used as exclusion masks. This ensured that the 
tracked connection contained paths connecting STN to M1, and at the same time not 
connecting STN to any of the other two targets. Similarly, for the other two target 
regions. 
 
2.6.3 DBS-Cortical connectivity 
A connectivity matrix was generated between all seed points in the combined (total) 
VTA area mask and all points in the cortical target masks (i.e. M1, SMA and PFC) 
using the output from tractography. The streamline counts for each voxel were 
normalised by the total number of streamlines reaching all targets to acquire a 
proportional measure. A t-statistic was used to calculate the connectivity within the 
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individual DBS-contact VTAs (inside) versus the connectivity outside the contact 
VTAs but within the combined (total) group average VTA and this value was used in 
subsequent regressions (denoted as CON). This value effectively reflected 
connectivity of voxels activated in a certain stimulation condition, using connectivity 
in inactive STN voxels as a baseline. An in-house Matlab (Mathworks Inc.) script was 
used to test the relationship between the cortical connectivity of individual DBS-
contact VTA voxels and the improvement in efficacy associated with each DBS-
contact VTA. To account for the effect of VTA volume and stimulation amplitude on 
efficacy, these factors were used as nuisance covariates in the regression analysis. 
Efficacy for alleviation of a particular symptom was then modelled as a linear 
combination of the connectivity values to each of the three target areas, VTA volume 
and stimulation voltage, as shown below. Alleviation of three symptoms was 
individually explored (tremor, bradykinesia and rigidity). All the explanatory 
variables (EVs) were normalised (demeaned and standard deviation made equal to 1), 
so that  
 
Efficacy = b0 + b1×CONVTA M1 + b2×CONVTA  SMA  + b3×CONVTA PFC  + 
b4×VOLTAGE + b5×VTA_VOLUME 
 
CON: connectivity; VTA: volume of tissue activated; M1: primary motor area; PFC: prefrontal cortex; 
SMA: supplementary motor area, b0-b5: unknown model parameters. 
 
3 Results 
 
3.1 Patients 
Scanning proceeded with no adverse effects. The mean pre-operative mini-mental 
score (MMS) was 29.6 (SD=0.6, Range=2). One patient had tremor-dominant PD 
without motor fluctuations. Six patients had no significant tremor and were therefore 
excluded from the tremor VTA efficacy and cortical connectivity analysis, but 
included in the rigidity and bradykinesia analyses. There was no surgical morbidity or 
mortality and all DBS leads landed within a mean (SD) of 0.8 (0.4) mm from the 
planned target. Patient demographics, improvement in UPDRS-III following L-DOPA 
administration (L-DOPA challenge, preoperatively), improvement in UPDRS-III one-
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year from surgery with DBS ON and OFF medications and change in L-DOPA 
equivalent daily dose are shown in table1.  
 
3.2 VTA Modelling 
Group average, statistically significant clusters correlated to stimulation efficacy and 
side-effect EVs within and around the STN are shown in Figures2 and 3. 
Improvement in bradykinesia, rigidity and tremor with DBS was associated with VTA 
clusters in the posterior, superior and lateral STN with the bradykinesia and rigidity 
areas extending to the superior border and being more medial and posterior than that 
of tremor. The three clusters were averaged into a single area in the superior and 
lateral STN with maximum intensity at X=-10(-9.5) Y=-13(-1) and Z=-7(-3) in MNI 
(AC-PC) space. Facial pulling was associated with VTA cluster in the region of the 
corticobulbar fibres. Acute dysarthria was associated with VTA cluster in the internal 
capsule. Diplopia was associated with the VTA cluster in the region of the 
mesencephalic oculomotor nerve fibres in the tegmentum. Paraesthesia was associated 
with the VTA cluster in the mid-portion and inferior STN. See Table2 for cluster 
volumes and MNI coordinates. 
 
3.3 Tractography 
 
3.3.1 Tractography from combined, group average, entire VTA area 
Six tracts were generated for each patient starting from the entire average VTA seed 
mask and ending in one of the predefined cortical targets in both hemispheres. Tracts 
to M1 ended mostly medially extending to the hand area. Group averages were 
produced for each tract class. The resulting six group average tracts are shown in 
Figure4. 
 
3.3.2 Tractography from bradykinesia, rigidity and tremor efficacy clusters 
Eighteen tracts ([3 efficacy seed clusters × 3 cortical targets] × 2 hemispheres) for 
each patient were generated using seed masks corresponding to efficacy clusters in the 
STN as shown in Figure3. Tract group averages were again produced for each tract 
class (i.e. individual efficacy clusters to M1, SMA and PFC). Only tracts ending in the 
medial aspect (superior frontal gyrus) of M1, SMA and PFC survived. This is shown 
in Figure4. 
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3.4 DBS-Cortical connectivity analysis 
 
Rigidity, bradykinesia and tremor had different VTA-cortical connectivity predictive 
profiles. Table3 shows which model parameters significantly contribute to predicting 
efficacy for each symptom.  In the case of rigidity, connectivity to SMA (b2~32 
[p=0.0006]) and PFC (b3~26 [p=0.005]) were highly significant. The effect was about 
half of that explained by voltage (b4~53 [p<0.0001]). For bradykinesia only 
connectivity to SMA was highly significant (b2~23 [p=0.005]). The effect was about 
two-thirds of that explained by voltage (b4~34 [p=0.001]). In the case of tremor, 
connectivity to the primary motor area was significant (b1~27 [p=0.04]). The effect 
was about a third of that explained by voltage (b4~80 [p<0.0001]). 
Figure5 shows the relationship between connectivity and efficacy for different 
stimulation amplitudes. Even if stimulation amplitude is a strong predictor of efficacy 
in all cases, the effect of connectivity can be also seen, particularly for rigidity and 
bradykinesia. For rigidity we can observe an upward trend for the efficacy as a 
function of the median connectivity to SMA. Particularly for intermediate voltages (2 
and 3 Volts), being at an STN sub-region with higher connectivity to SMA leads to 
higher efficacy in alleviating rigidity. For bradykinesia, there is not a clear trend for 
high voltages (3 and 4 volts), but low/medium stimulation (1 and 2 volts) seems to 
benefit from being at a location with a high SMA connectivity. Thus, when voltage is 
low, exact contact location within the STN really matters.  The profiles for tremor are 
much noisier and voltage amplitude clearly determines efficacy in this case. 
 
4 Discussion 
 
Voxel based statistical analysis of volumes of tissue activated, at increasing 
amplitudes, around individual DBS contacts, one year after STN DBS was used in 20 
patients with Parkinson’s disease (14 patients in the case of tremor) to (1) map out 
statistically significant clusters in the STN area, reflecting efficacy and side effects 
zones; (2) generate probabilistic tractography streamlines (hyperdirect pathways) 
from said volumes to predefined cortical areas [M1, SMA and PFC] and (3) identify 
the pattern of cortical connectivity that predicts response to treatment. 
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Appropriately selected patients responded well to DBS with reduction in LEDD and 
improvement in UPDRS-III both ON and OFF medications one-year post op (Table1).  
 
4.1 Efficacy and side-effects clusters in the STN region 
 
Using a statistical analysis approach akin to that used in voxel based morphometry, 
distinct clusters in the STN corresponding to improvement in rigidity, bradykinesia 
and tremor are demonstrated (Figures 2 and 3). All clusters are in the supero-lateral 
(motor) STN with overlapping bradykinesia and rigidity clusters. The tremor cluster is 
central within the supero-lateral STN whilst rigidity and bradykinesia appear to be 
more medial, posterior and superior. The rigidity cluster is the largest of the three and 
extends beyond the STN into the subthalamic region in the area of rostral ZI and 
Forel-H2 field (pallido-thalamic fibres) whilst the bradykinesia cluster does not extend 
beyond the STN border (Schaltenbrand et al., 1977). The average cluster with overall 
maximum improvement in all motor symptoms lies in the superior-lateral portion of 
the STN. 
This pattern could partly explain the disparity in the findings of previous reports 
exploring the best stimulation site. It is now apparent that improvement in different 
motor symptoms might be associated with stimulation of different sites in and around 
the STN. This is not a novel notion, Cintas and colleagues showed that improvement 
in tremor, rigidity and bradykinesia can follow stimulation in different contacts 
(Cintas et al., 2003).  Clusters corresponding to familiar side effects encountered with 
stimulation in well-established anatomical locations validate our findings (Figure2). 
It is paramount to highlight that the stimulation effect presented (for efficacy and 
side-effects) is a response to acute stimulation (during screening) and not long-term 
stimulation. This is an especially important point with regard to delayed emergence of 
side-effects resulting from chronic stimulation, particularly deterioration in speech 
intelligibility. The optimal DBS target may eventually vary according to emergence of 
such side-effects (Plaha et al., 2008; Tripoliti et al., 2013). 
There are two main problems of carrying out a group analysis examining efficacy of 
individual DBS contacts. The first is the variability in the STN between individuals 
(and hemispheres in the same individual) and the method to describe contact 
locations. Using categorical, arbitrary division within the nucleus reduces sensitivity 
and specificity of the analysis. It also introduces observer bias. We overcame this 
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problem by using a unique probabilistic STN template generated from our patient 
group, in order to visualise the resulting clusters, and co-registering volumes of tissue 
activation to MNI space. We tested voxels independently in the analysis across all 
contacts/ voltages for each individual, increasing the sensitivity and specificity of our 
approach. 
The second problem is adjusting for baseline inhomogeneity. This is often overlooked 
and can produce statistical anomalies (e.g. a 5-point improvement from a baseline of 
10 gives the same percentage of improvement of 30 from a baseline of 60) (Vickers, 
2001; Zaidel et al., 2010). In order to overcome this, we examined efficacy clusters in 
each patient individually. The resultant clusters were then averaged across the entire 
group.  
 
4.2 Tractography and cortical connectivity fingerprint  
 
In vivo tractography studies in the region of the STN carry significant challenges. 
Motion artefacts, as a result of the highly pulsatile nature of the brainstem region, can 
degrade the MRI signal during diffusion image acquisition, reducing the signal-to-
noise ratio (SNR). This is complicated by the presence of myriad criss-crossing axons 
and reticular brain regions (Lambert et al., 2013a; 2013b). One way of dealing with 
this is by using pulse-gating and respiratory rate monitoring during diffusion imaging. 
Likewise, by acquiring multiple diffusion scans, at a high angular resolution 
(increasing acquisition time), SNR is improved (Behrens et al., 2007; 2003). 
Several studies have indeed used tractography to examine STN connectivity to 
cortical and subcortical areas but most used diffusion MR acquisition parameters 
more suited for conventional clinical application, such as mapping major white matter 
tracts prior to surgical intervention with low angular resolution (number of diffusion 
directions ≤ 64), low spatial resolution (voxel size ≥ 2mm) and low angular contrast 
(b-value=1000s/mm
2
) (Aravamuthan et al., 2007; Avecillas-Chasin et al., 2016; 
Vanegas-Arroyave et al., 2016). Choosing the appropriate diffusion imaging 
parameters is of particular importance in the STN. This is in part due to its relatively 
small dimensions (12 mm in the longest axis and 4 mm in maximal thickness) 
(Schaltenbrand et al., 1977) requiring small voxel dimensions; and low fractional 
anisotropy (grey matter) requiring higher diffusion sensitisation (b-value).  
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We acquired 270 diffusion scans per patient (in 2×128 directions sets) over 62 
minutes. We meticulously and systematically corrected artefacts and examined the 
processed imaging data for quality control. We modelled three crossing fibres per 
voxel and used probabilistic tractography to ameliorate the crossing fibre problem.  
Recently, there has been a tendency to use tractography in an exploratory fashion. 
Though there is a place for this in delineating large white matter bundles, the results 
should always be scrutinised for false positives. Tunnel effect, crossing and kissing 
fibres pose particular difficulties (Behrens et al., 2007; Dyrby et al., 2007). In order to 
keep the analysis focused, a set of tractography rules based on knowledge from 
neurophysiological and NHP tracer studies was used, without being too restrictive. 
The effect of STN-cortical connectivity was examined rather than simply described. 
The precise role of the cortico-STN hyperdirect pathway remains to be fully 
understood. It has been proposed that, through this pathway, direct cortical 
information reaches the STN before indirect cortical output via the cortico-basal 
ganglia route. This potentially allows for direct cortical modulation of STN output 
(Rektor et al., 2015). 
Our working hypothesis was that STN DBS exerted an effect through the hyperdirect 
pathway. The results suggest that three hyperdirect pathways connect the combined 
electrode stimulation area in and around the STN. Furthermore, distinct connectivity 
patterns predict response to DBS. Connectivity to M1 appears to predict improvement 
in tremor; to SMA predicts improvement in bradykinesia; and to both SMA and PFC 
for improvement in rigidity. Purely visualising the tractography results from the 
subthalamic region to the distinct cortical areas is not informative by itself, however; 
the GLM analysis, examining the relationship with efficacy, illustrates that 
connectivity is indeed relevant to a degree that is comparable to that of DBS voltage.  
This model fits with functional and anatomical expectations. A non-human primate 
tracer study examining the hyperdirect pathway shows that M1 STN terminals occupy 
the dorsolateral portion of the STN; whilst SMA and PFC terminals are more 
medially located, with areas of overlap between M1 and SMA; and SMA and PFC 
(Haynes and Haber, 2013). 
From a functional perspective; the primary motor area, SMA and PFC command sub-
specialised roles in motor control. PET and SPECT studies have shown reduced 
metabolism in the PFC and SMA with Parkinson’s disease progression (Eidelberg, 
2009; Huang et al., 2007; Ma et al., 2007). The SMA is typically concerned with 
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motor encoding and planning, whereas M1 is implicated with motor execution and the 
PFC plays a role in cognitive/ behavioural motor response selection and proactive 
motor inhibition (Jahanshahi et al., 2015a; 2015b; I. Obeso et al., 2013a). DBS of the 
STN, by impacting on different fronto-basal ganglia pathways, has been shown to 
produce differential effects on reactive and proactive inhibition and on conflict 
resolution (I. Obeso et al., 2013b). 
Resting tremor in Parkinson’s disease is thought to be pathologically separate from 
bradykinesia and rigidity. The severity and magnitude of tremor is not related to the 
amount of dopamine deficiency in the substantia nigra and response to dopamine 
replacement can be poor in comparison to response in other motor symptoms (Bostan 
et al., 2010; Hallett, 2012; Ni et al., 2010; Timmermann et al., 2003). Pathological 
oscillations in a cerebello-thalamo-cortical network, possibly triggered by pallidal 
dysfunction in Parkinson’s disease, is thought to be culpable (Helmich et al., 2011). 
The cortical focus in this tremor network is in the primary motor cortex and not the 
SMA. This is supported by evidence from a transcranial magnetic stimulation (TMS) 
study that demonstrated tremor suppression following stimulation of the primary 
motor cortex (Ni et al., 2010). 
A resting state functional MRI study has also shown increase in connectivity between 
the STN and hand area of M1 and the primary sensory cortex tremor-dominant 
subgroup; conversely, in a non-tremor subgroup, increased connectivity was found 
between the STN and wider cortical areas including the SMA as well as M1 
(Baudrexel et al., 2011). Another study that used resting state fMRI showed that STN 
DBS modulates the hyperdirect M1-STN projections (Kahan et al., 2014). 
Two confounding factors are present when testing cortical connectivity of the 
volumes of tissue activated around each contact. The increase in tissue volume leads 
to an increase in the number of tractography voxel seeds. This, in turn, increases the 
number of streamlines from the VTA to the cortex in a non-linear fashion. The second 
confounding factor arises from the inexact relationship between stimulation 
amplitudes and increasing efficacy. Especially because the local population of 
neurons may have different action-potential thresholds. For this reason, voltage and 
seed volume effects were made covariates to study their effect on efficacy as well as 
that of the connectivity profile. 
In the case of rigidity, an upward trend for all voltages was noted, particularly for 
low/medium voltages (e.g. 2 and 3 Volts) with higher connectivity to PFC and SMA, 
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resulting in higher efficacy. For bradykinesia, the plot shows no clear trend for high 
voltages (3 and 4) but an upward trend for low voltages (1 and 2 Volts). In other 
words, when voltage is low, it matters most where the STN is stimulated. The tremor 
plot shows that voltage clearly determines efficacy in this case with a slight upward 
trend for voltages 1 and 3. 
We focused the tractography analysis on hyperdirect pathways to three cortical areas 
known to be involved in tone control, motor initiation, planning and execution. We 
cannot rule out the existence of other cortical-STN pathways that may also influence 
outcome from DBS. Our analysis did not explore the influence of STN-subcortical 
connectivity (e.g. thalamic/ striatal). The reason for this is two-fold: the strength of 
tractography diminishes with distance rendering DBS-subcortical connectivity 
artificially stronger than DBS-cortical connectivity; and the combined VTA area 
clearly encroaches on the thalamic border as shown in Figure1. It is, therefore, hardly 
surprising to find an increase in connectivity between volumes of tissue activated and 
the thalamus, as was demonstrated in a recent study (Vanegas-Arroyave et al., 2016).   
The efficacy cluster analysis we carried out does not address potential covariance 
within symptoms per se. We therefore cannot assert that the three areas are 
independent of each other based on the VBM analysis alone (especially in the case of 
rigidity and bradykinesia clusters), however; there is a clear difference in cortical 
connectivity pattern predictive of improvement in individual symptoms. This 
difference is supported by anatomical and functional studies as described in the 
discussion. We show that the average cluster lies in the dorsal-lateral portion of the 
STN in keeping with existing wisdom. We opted not to explore this relationship 
between the individual clusters further as this has little significance in clinical 
practice, as a well-placed DBS electrode can easily straddle the three areas. 
Nevertheless, carrying out the VBM analysis separately has produced convergent 
efficacy clusters in close proximity. This substantiates the novel technique used here. 
 
4.3 Limitations 
 
In this study, a patient specific, finite element model is used to create DBS-VTAs 
(Åström et al., 2008). This is a simplified linear model that does not account for local 
impedance inhomogeneity (Howell and McIntyre, 2017). While it is important efforts 
are put into improving DBS models to resemble reality, it may not help to add details 
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to a rough model when the basic knowledge of the DBS mechanisms of actions are 
still debated. Indeed, various models over- or under-estimate the VTA (Maks et al., 
2009). The presence of axons of different diameters and cell bodies, with variable 
action-potential thresholds, in the DBS region, complicates matters further. Our other 
justification for not using a more complex model is the fact that minute variations in 
VTAs are unlikely to have a large effect on statistical analysis and tractography 
results, due to the relatively larger spatial resolution of our structural and diffusion 
MRI data. Although the number of patients was relatively small (20 for the analysis of 
bradykinesia and rigidity analysis and 14 for the tremor analysis), we analysed two 
cerebral hemispheres independently by investigating hemi-body effects of stimulation 
doubling up the overall number in the analysis. Furthermore, testing the effect of 
stimulation for each individual contact at different voltages provided more data points 
per hemisphere. The main reason for the relatively small number of subjects stems 
from the difficulty in recruiting patients with advanced Parkinson’s disease who are 
successfully selected for STN-DBS and can also tolerate having a lengthy MRI scan. 
We assessed stimulation efficacy in the upper limbs and not the lower limbs. We 
judged that this would give a more quantifiable and reproducible measure of 
improvement. Furthermore, patients with significant lower limb symptoms are seldom 
good candidates for STN-DBS. This does however mean that our results concerning 
the efficacy spots cannot directly be transferrable to patients with lower limb 
symptoms. 
Another limitation is the inherent diffusion MRI imperfections as detailed in the 
discussion. Further improvements in diffusion imaging, with higher spatial and 
angular resolution and improved MRI gradients will add to the value of this modality 
(Jbabdi and Johansen-Berg, 2011; Sotiropoulos et al., 2013). 
Multiple registration steps introduce error to the system. Nonetheless; we 
meticulously confirmed registration accuracy at each step to alleviate the impact of 
this issue. Manual STN delineation introduces observer bias; however, using two 
experienced clinicians to perform this independently reduced inaccuracy. 
Furthermore, by using a group average imprecisions were minimized. Prior to 
carrying out the VTA cluster analysis, we lateralized the right sided DBS contacts and 
STN to the left. This approach is commonly used in imaging studies; however, it 
assumes no functional differences between the left and right STN. Given that the 
lateralised structures differ in size in our right hand dominant cohort, we must 
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acknowledge the possible existence of different connectivity and efficacy 
relationships according to STN laterality. However, although reports have pointed to 
the existence of lateralised differences in emotional processing, no such differences 
have been established in motor processing (Eitan et al., 2013). 
Another limitation in the efficacy and side effect cluster analysis is the autocorrelation 
in the data. The VTAs, by definition, have a degree of overlap which increases the 
power but theoretically also increases the risk of false positives. This is certainly a 
weakness of the analysis. Having said that, spatial autocorrelation is a well-known 
phenomenon in VBM and fMRI analysis and permutation tests do not easily 
accommodate correlated datasets, as such dependence violates null-hypothesis 
exchangeability, however; it is suggested that non-parametric permutation testing is 
less amenable to false positives than parametric permutations (Kriegeskorte et al., 
2008). We have also carried out the analysis for each subject separately to reduce the 
effect of inter-individual variability. 
Lastly, the relatively long scan duration is a drawback. This was accepted to achieve 
the required SNR and resolution. However, novel MRI acquisition techniques 
(Simultaneous Multi-Slice Imaging and Multi-Band Imaging) (Feinberg and 
Setsompop, 2013) have been developed that will allow future studies to run similar 
protocols within half the time without compromising the SNR. 
 
5 Conclusion 
 
The optimal DBS site for patients with Parkinson’s disease for tremor, bradykinesia 
and rigidity appears to correspond to different areas in the motor STN.  Stimulation in 
the central portion of the superior STN is most effective for tremor, whilst stimulation 
in further medial and posterior areas, within the superior portion, gives highest 
improvements in bradykinesia and rigidity. DBS-cortical connectivity, along the 
hyperdirect pathways, to M1 is predictive of maximum improvement in tremor, to 
SMA is predictive of maximum improvement in bradykinesia and to both SMA and 
PFC is predictive of maximum improvement in rigidity. 
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8 Figure legend 
 
Table 1: Patient demographics, preoperative L-DOPA challenge, postoperative 
change in UPDRS III and medication requirement 
*: At surgery; **: At 12 months; ϯ: 2-tailed paired-t test; CI: Confidence Interval; 
Med: Medications; SD: Standard deviation; SE: Standard error; df: degrees of 
freedom; LC: L-DOPA Challenge (preoperative); LEDD: L-DOPA equivalent daily 
dose 
 
Table 2: Volume of tissue activated significant clusters with maximum effect and 
centre of gravity coordinates in MNI and corresponding AC-PC space 
VTA: Volume of tissue activation; VOL: Volume; P-VAL: p-value; AC: anterior 
commissure; PC: posterior commissure 
 
Table 3. Model parameters that significantly contribute to the efficacy 
prediction.  
P values correspond to testing each parameter being different from zero.  
Con: connectivity 
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Figure 1: STN and VTA modelling, co-registration and analysis pathways  
The graph on the left shows examples of STN, DBS lead and VTA modelling in 
SureTune package. Transformation from native space to MNI space is shown for STN 
and VTA models. Tractography to M1 is shown in red, to SMA in blue and to PFC in 
green. The graph on the right shows group average STN in green and total VTA area 
in red-yellow (IC: internal capsule; PFC: prefrontal cortex; SMA: supplementary 
motor area; M1: primary motor area; VTA: volume of tissue activated)   
 
Figure 2: Volume of tissue activated significant clusters for maximum efficacy 
and emergence of side effects of subthalamic nucleus deep brain stimulation (z 
coordinate is in MNI space) Group average STN is shown in green 
 
Figure 3: Volume of tissue activated significant clusters of subthalamic nucleus 
deep brain stimulation (MNI–Z = -7mm) *  
*Group average STN is shown in green. All clusters were corrected for multiple 
comparisons using non-parametric (gold-standard) approaches 
 
Figure 4: Group average tractography: from the combined overall average VTA 
mask– left and from the combined efficacy clusters - right to M1 (red), SMA 
(blue) and PFC (green) 
 
Figure 5: Plots showing relationship between percentage improvement in 
efficacy and VTA-cortical connectivity with stimulation amplitude (right) for 
rigidity, bradykinesia and tremor. The connectivity of all voxels belonging to the 
respective VTA vs efficacy is illustrated with the scatter plots on the left. The median 
of these connectivity values is plotted vs efficacy on the right. Connectivity is defined 
as a t-score between the normalized streamline count of the activated STN region and 
the streamline count of the non-activated STN region, i.e. the latter is used as a 
“baseline” connectivity in each case. 
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 Table 1: Patient demographics, preoperative L-DOPA challenge, postoperative change 
in UPDRS III and medication requirement 
 Mean SD SE Minimum Maximum Range 
Age* 56.3 10.2 2.3 41 71 30 
Disease duration* 11.2 4.3 1.0 4 22 18 
Duration of motor fluctuations* 3.1 2.0 0.4 0 9 9 
UPDRS III OFF (LC) 43.8 13.0 3.0 20 73 53 
UPDRS III ON (LC) 17.4 9.9 2.3 4 42 38 
UPDRS III Improvement (LC) 
95% CI:21.6-31.3, t:11.4, df:18, p<0.0001ϯ 
26.5 
(61%) 
10.1 
(15.8%) 
2.3 
(3.6%) 
7 
(33%) 
47 
(91%) 
40 
(58%) 
UPDRS III (OFF Med. OFF DBS) ** 50.5 17.2 3.9 24 96 72 
UPDRS III (OFF Med. ON DBS) ** 27.1 12.5 3.0 14 51 37 
UPDRS III Improvement** 
95% CI:16.8-29.4, t:7.5, df:16, p<0.0001ϯ 
23.4 
(46%) 
12.8 
(17.4%) 
3.1 
(4.2%) 
8 
(22%) 
45 
(73%) 
37 
(51%) 
UPDRS III ON Med. OFF DBS** 27.6 14.1 3.2 10 62 52 
UPDRS III ON Med. ON DBS** 13.3 9.1 2.2 3 34 31 
UPDRS III Improvement** 
95% CI:10.4-18.3, t:7.6, df:17, p<0.0001ϯ 
14.3 
(52%) 
8.0 
(17.4%) 
1.9 
(4.1%) 
41 
(9%) 
28 
(81%) 
24 
(62%) 
LEDD (Preoperative) 1365.6 509.8 114 540 2550 2010 
LEDD (Postoperative) 770.6 306.6 68.6 320 1266 946 
LEDD Reduction with DBS 
95% CI: 386.3-803.8, t:6, df:19, p<0.0001ϯ 
595 
(44%) 
203.2 
(39.9%) 
45.4 
(39.8%) 
220 
(40.7%) 
1284 
(50.4%) 
1064 
(52.9%) 
 
*: At surgery; **: At 12 months; ϯ: 2-tailed paired-t test; CI: Confidence Interval; Med: Medications; SD: 
Standard deviation; SE: Standard error; df: degrees of freedom; LC: L-DOPA Challenge (preoperative); LEDD: 
L-DOPA equivalent daily dose 
 
Table 1
Table 3. Model parameters that significantly contribute to the efficacy prediction.  
 Con STN-M1 
(b1>0) 
Con STN-SMA 
(b2>0) 
Con STN-PFC 
(b3>0) 
Voltage 
(b4>0) 
VTA-Volume 
(b5>0) 
Rigidity p=0.035 p=0.0006 p=0.005 p=10-6 p=0.02 
Bradykinesia p>0.05 p=0.005 p>0.05 p=0.001 p>0.05 
Tremor p=0.04 p>0.05 p>0.05 p=10-7 p>0.05 
P values correspond to testing each parameter being different from zero.  
Con: connectivity 
 
Table 3
Table 2: Volume of tissue activated significant clusters with maximum effect and centre 
of gravity coordinates in MNI and corresponding AC-PC space 
 
 
VTA: Volume of tissue activation; VOL: Volume; P-VAL: p-value; AC: anterior commissure; PC: posterior 
commissure 
 
VTA Cluster VOL (mm3) P-VAL 
Maximum effect coordinates 
MNI (AC-PC) 
Centre of gravity coordinates 
MNI (AC-PC) 
X Y Z X Y Z 
Rigidity 62 0.006 -9 (-8.5) -13 (-1) -7 (-3) -11 (-10.5) -15 (-3) -7 (-3) 
Bradykinesia 6 0.037 -11 (-10.5) -14 (-2) -7 (-3) -11 (-10.5) -14 (-2) -7 (-3) 
Tremor 11 0.014 -11 (-10.5) -12 (0) -6 (-2) -12 (-11.5) -12 (0) -6 (-2) 
Combined 26 - -10 (-9.5) -13 (-1) -7 (-3) -11 (-10.5) -14 (-2) -7 (-3) 
Facial pulling 77 0.012 -11 (-10.5) -19 (-7) -1 (3) -12 (-11.5) -18 (-6) -2 (2) 
Dysarthria 149 0.002 -17 (-16.5) -12 (0) -5 (-1) -15 (-14.5) -11 (1) -2 (2) 
Diplopia 185 0.002 -7 (-6.5) -12 (0) -15 (-11) -7 (-6.5) -16 (-4) -12 (-8) 
Paraesthesia 475 0.002 -10 (-9.5) -20 (-8) -18 (-14) -11 (-10.5) -15 (-3) -12 (-8) 
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